Literature DB >> 20531168

Restoration of meibomian gland functionality with novel thermodynamic treatment device-a case report.

Donald R Korb1, Caroline A Blackie.   

Abstract

A new and previously unpublished thermodynamic treatment device, which for the first time applies heat directly to both inner eyelid surfaces with a precision-controlled resistive heater while pulsating pressure is simultaneously applied to the outer eyelids using an inflatable air bladder, was used to restore meibomian gland functionality for a subject with severe evaporative dry eye. The subject, a 39-year-old white woman of light complexion with severe symptoms and corroborating objective signs of dry eye, had been unsuccessfully treated for 3 years by 7 practitioners. Using a new standardized meibomian gland expression device, a diagnosis of nonobvious meibomian gland dysfunction, where none of the approximately 24 meibomian glands of the right lower eyelid and 1 meibomian gland of the left lower eyelid were functional, was made. The patient underwent a single 12-minute treatment per eye with the treatment device. The treatment restored the functionality of 8 glands in each eye, doubled the fluorescein break-up time (FBUT) from 5 to 10 seconds, and decreased the symptom scores by approximately 80% for the entire follow-up period of 3 months.

Entities:  

Mesh:

Year:  2010        PMID: 20531168     DOI: 10.1097/ICO.0b013e3181ca36d6

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  16 in total

Review 1.  Intense Pulsed Light Therapy In The Treatment Of Meibomian Gland Dysfunction: Current Perspectives.

Authors:  Giuseppe Giannaccare; Leonardo Taroni; Carlotta Senni; Vincenzo Scorcia
Journal:  Clin Optom (Auckl)       Date:  2019-10-17

2.  The optimum temperature for the heat therapy for meibomian gland dysfunction.

Authors:  Douglas Borchman
Journal:  Ocul Surf       Date:  2019-02-19       Impact factor: 5.033

3.  Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study.

Authors:  Rolando Toyos; William McGill; Dustin Briscoe
Journal:  Photomed Laser Surg       Date:  2015-01       Impact factor: 2.796

4.  Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction.

Authors:  Sin Man Lam; Louis Tong; Xinrui Duan; U Rajendra Acharya; Jen Hong Tan; Andrea Petznick; Markus R Wenk; Guanghou Shui
Journal:  J Lipid Res       Date:  2014-07-03       Impact factor: 5.922

Review 5.  Image-guided evaluation and monitoring of treatment response in patients with dry eye disease.

Authors:  Yureeda Qazi; Shruti Aggarwal; Pedram Hamrah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-04       Impact factor: 3.117

6.  The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye.

Authors:  Caroline A Blackie; Christy A Coleman; Edward J Holland
Journal:  Clin Ophthalmol       Date:  2016-07-26

7.  Evaluation of the Safety and Effectiveness of Intense Pulsed Light in the Treatment of Meibomian Gland Dysfunction.

Authors:  Xiaodan Jiang; Huibin Lv; Hang Song; Mingzhou Zhang; Yan Liu; Xiaodan Hu; Xuemin Li; Wei Wang
Journal:  J Ophthalmol       Date:  2016-06-20       Impact factor: 1.909

8.  Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction.

Authors:  Steven L Maskin; Whitney R Testa
Journal:  Br J Ophthalmol       Date:  2017-06-07       Impact factor: 4.638

9.  Meibomian gland dysfunction patients with novel Sjögren's syndrome biomarkers benefit significantly from a single vectored thermal pulsation procedure: a retrospective analysis.

Authors:  Alice T Epitropoulos; Krysta Goslin; Raman Bedi; Caroline A Blackie
Journal:  Clin Ophthalmol       Date:  2017-04-13

Review 10.  Emerging treatment options for meibomian gland dysfunction.

Authors:  Jing Qiao; Xiaoming Yan
Journal:  Clin Ophthalmol       Date:  2013-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.